Sign in
Risk for Sight-Threatening Diabetic Retinopathy With GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes
Andrew J. Barkmeier, MD
Annual Meeting Talks
2024
Comparative Evaluation of Review Strategies for Detection of Vascular Abnormalities on Optical Coherence Tomography Angiography in the AVATAR Study
Amy S. Babiuch, MD, FASRS
On Demand Cases, Courses, and Papers
2017
Aflibercept 8 mg for Diabetic Macular Edema: 2-Year Results of the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
2023
Category: Imaging